Literature DB >> 32319714

Lung nuclear protein in testis carcinoma in an elderly Korean woman: A case report with cytohistological analysis.

Hwa Jin Cho1, Hyun-Kyung Lee2.   

Abstract

Nuclear protein in testis (NUT) carcinoma is a rare, aggressive carcinoma that is a diagnostic challenge for pathologists. Here, we report a case of NUT carcinoma in a 63-year-old woman with uncommon immunohistochemical results. The initial bronchoscopic biopsy revealed a poorly differentiated carcinoma with p63 immunohistochemical stain positivity. However, the cytomorphological features of the pleural fluid were unusual. Immunohistochemical staining of the pleural fluid revealed diffuse positivity for vimentin and focal positivity for cytokeratin and neuroendocrine markers. Because of chemoresistance, other malignancies, including sarcomatoid carcinoma, combined small cell carcinoma, and an unusual form of NUT carcinoma, were considered as differential diagnoses. The diagnosis of NUT carcinoma was confirmed using NUT-specific antibodies and fluorescence in situ hybridization. The current case was a diagnostic challenge because of the poorly differentiated cytomorphology and uncommon immunohistochemical results. Pathologists and clinicians should consider NUT carcinoma in the differential diagnosis, as this malignancy has a dismal prognosis and needs to be diagnosed accurately for the most effective treatment. KEY POINTS: Metastatic NUT carcinoma can show diffuse vimentin positivity and focal neuroendocrine marker positivity. NUT carcinoma can be misdiagnosed as basaloid squamous cell carcinoma in routine diagnosis, especially in older-aged patients. This study was a diagnostic challenge because of the poorly differentiated cytomorphology and uncommon immunohistochemical results for NUT carcinoma. Pathologists should differentially diagnose NUT carcinoma when rare cytohistological features are observed at any age.
© 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Case report; NUT carcinoma; immunohistochemical analysis; pulmonary

Year:  2020        PMID: 32319714      PMCID: PMC7262936          DOI: 10.1111/1759-7714.13438

Source DB:  PubMed          Journal:  Thorac Cancer        ISSN: 1759-7706            Impact factor:   3.500


Introduction

Nuclear protein in testis (NUT) carcinoma is a rare, aggressive carcinoma involving NUT rearrangement. It may arise at any age (0.1–81.7 years), but on the basis of the median patient age, it usually occurs in childhood or young adulthood (ie, 16–24 years).1, 2, 3, 4 NUT carcinoma is refractory to conventional chemotherapy and has a dismal prognosis.2, 3 NUT carcinoma is often misdiagnosed because of its various morphologies, leading to inappropriate treatment. Here, we report a case of NUT carcinoma of the lung in an elderly woman with uncommon immunohistochemical results.

Case report

A 63‐year‐old woman presented with complaints of right flank pain, cough, and breathing difficulties for two months. Her initial laboratory test results were normal. Initial computed tomography (CT) scan showed a large amount of right pleural effusion and consolidation in the right middle lobe. On the second chest CT after percutaneous drainage, suspicious findings indicative of endobronchial central lung cancer with obstructive pneumonitis were observed (Fig 1).
Figure 1

Small residual amount of right pleural effusion with subsegmental atelectasis in the right lower and middle lobe. Bronchial wall thickening and stenosis with peribronchial soft‐tissue infiltration along the right main and intermediate as well as all three lobar bronchi. Ill‐defined soft tissue infiltrations at the subcarinal and lower paratracheal area, suggestive of endobronchial central lung cancer with obstructive pneumonitis.

Small residual amount of right pleural effusion with subsegmental atelectasis in the right lower and middle lobe. Bronchial wall thickening and stenosis with peribronchial soft‐tissue infiltration along the right main and intermediate as well as all three lobar bronchi. Ill‐defined soft tissue infiltrations at the subcarinal and lower paratracheal area, suggestive of endobronchial central lung cancer with obstructive pneumonitis. A bronchoscopic biopsy specimen revealed nests of small‐to‐intermediate‐sized, monomorphic cells with vesicular nuclei. Frequent nuclear molding and distinct nucleoli were observed (Fig 2a,b). Results of immunohistochemical staining are shown in Table 1 and Fig 2c,d. Because cells were positive for p63 and CK5/6, an initial diagnosis of basaloid squamous cell carcinoma (SqCC) was made. Positron emission tomography‐CT (PET‐CT) showed no extrathoracic organ metastasis.
Figure 2

Pathological findings of NUT carcinoma. a–d: Microscopic findings of tumor obtained from bronchoscopic biopsy. (a) Nests of small‐to‐intermediate‐sized monomorphic cells infiltrating the bronchial mucosa. (b) Frequent nuclear molding and prominent nucleoli. (c) Diffuse strong nuclear p63 positivity. (d) Diffuse positivity of CK5/6. e–i: Pleural fluid cytomorphology observed on immunohistochemical staining. (e) Hyperchromatic malignant cell clusters in the liquid‐based preparation (inlet) and cell block. (f) Diffuse vimentin positivity. Focal positivity for (g) pancytokeratin, (h) chromogranin, and (i) synaptophysin. (j) and (k) NUT evaluation with pleural fluid effusion. (j) Immunohistochemical staining of NUT antibody showing diffuse positivity. (k) Frequent chromosomal translocation in the NUT gene (NUTM1), as observed using the fluorescence in situ hybridization break‐apart probe. (Original magnification and stain: a: ×100; b, c, and d: ×200; e–i: ×200; a and b: H&E; c: p63; d: CK5/6; e: H&E; f: vimentin; g: pancytokeratin; h: chromogranin; i: synaptophysin; j: NUT)

Table 1

Immunohistochemical analysis results of the primary and metastatic tumors in the pleural fluid

PositivityExtent
Initial tumor from the RML bronchus
TTF‐1NegativeNA
Napsin ANegativeNA
P63PositiveDiffuse
Cytokeratin 5/6PositiveDiffuse
CD56NegativeNA
PancytokeratinPositiveDiffuse
Residual tumor from the RML bronchus after 11 months
TTF‐1NegativeNA
P63PositiveFocal
CD56PositiveFocal
Cytokeratin 7PositiveDiffuse
Metastatic tumor in the pleural fluid after 11 months
TTF‐1NegativeNA
P63PositiveFocal
CD56PositiveFocal
ChromograninPositiveFocal
SynaptophysinPositiveFocal
Pan‐cytokeratinPositiveFocal
VimentinPositiveDiffuse
CalretininNegativeNA
HBME‐1NegativeNA

NA, not applicable; RML, right middle lobe.

Pathological findings of NUT carcinoma. a–d: Microscopic findings of tumor obtained from bronchoscopic biopsy. (a) Nests of small‐to‐intermediate‐sized monomorphic cells infiltrating the bronchial mucosa. (b) Frequent nuclear molding and prominent nucleoli. (c) Diffuse strong nuclear p63 positivity. (d) Diffuse positivity of CK5/6. e–i: Pleural fluid cytomorphology observed on immunohistochemical staining. (e) Hyperchromatic malignant cell clusters in the liquid‐based preparation (inlet) and cell block. (f) Diffuse vimentin positivity. Focal positivity for (g) pancytokeratin, (h) chromogranin, and (i) synaptophysin. (j) and (k) NUT evaluation with pleural fluid effusion. (j) Immunohistochemical staining of NUT antibody showing diffuse positivity. (k) Frequent chromosomal translocation in the NUT gene (NUTM1), as observed using the fluorescence in situ hybridization break‐apart probe. (Original magnification and stain: a: ×100; b, c, and d: ×200; e–i: ×200; a and b: H&E; c: p63; d: CK5/6; e: H&E; f: vimentin; g: pancytokeratin; h: chromogranin; i: synaptophysin; j: NUT) Immunohistochemical analysis results of the primary and metastatic tumors in the pleural fluid NA, not applicable; RML, right middle lobe. The tumor progressed despite multiple rounds of chemotherapy and showed metastasis to abdominal lymph nodes and the liver; therefore, a second biopsy and percutaneous drainage were performed 11 months later. Liquid‐based preparation and cell‐block analysis of the pleural fluid were performed (Fig 2e–i). The tumor cells showed a singly scattered or tightly clustered pattern. The nuclei were hyperchromatic, and the nuclear chromatin pattern was coarse, with prominent nucleoli. The tumor was diffusely positive for vimentin and focally positive for pancytokeratin, p63, and neuroendocrine markers. A diagnosis of mixed sarcomatoid, squamous, and small cell carcinoma was made. Differential diagnoses including unusual NUT carcinoma and sarcomatoid malignant mesothelioma were considered. Additional NUT immunohistochemical staining (1:100, C52B1, Cell Signaling Technology, Danvers, MA, USA) revealed positivity in the nuclei (Fig 2j). Chromosomal translocation in the NUT gene (NUTM1) was observed using break‐apart fluorescence in situ hybridization (FISH) (Fig 2k). NUT carcinoma was finally diagnosed. Clinically, the tumor progressed over 13 months, and the last chest CT showed progressive lung cancer with extensive pleural metastasis. The patient was discharged to a local hospital for supportive care, but she was lost to follow‐up.

Discussion

This case shows unusual immunohistochemical results associated with NUT carcinoma. The patient's older age and the difference in cytohistological features of primary and metastatic carcinoma in the pleural fluid resulted in difficulty in making an accurate diagnosis. A recent study of NUT carcinoma in Korea reported a median age of 48.0 years (range, 8–73 years), which was higher than that reported in Western studies (30 years).5, 6 NUT carcinoma is extremely aggressive and has a dismal prognosis. Diagnosing NUT carcinoma has been challenging, primarily because its cytological and histological morphologic features vary and overlap with those of some poorly differentiated or undifferentiated malignancies. The typical histological features are sheets and nests of monomorphic small‐to‐intermediate‐sized round‐oval cells. The amount of cytoplasm is scant‐to‐moderate, and the nuclear‐to‐cytoplasmic ratio is high, with frequent mitoses. Nuclei are vesicular to hyperchromatic. Additional histological findings such as mesenchymal differentiation7 have also been reported. The main differential diagnoses in the current case were small cell carcinoma, basaloid or poorly differentiated SqCC, the small cell variant of SqCC,8 combined small cell carcinoma and sarcomatoid carcinoma (in the pleural fluid), and other carcinomas showing a small round cell morphology, including NUT carcinoma.9 Immunohistochemical staining5, 6 and cytological specimens,8, 9, 10 along with radiological diagnostic methods like PET‐CT, are useful for differential diagnosis of NUT carcinoma of the lung. NUT carcinoma is usually positive for cytokeratins and p63 and negative for neuroendocrine markers.9 However, spotty AE1/AE3 and CD138 staining and diffuse vimentin positivity have been reported.11 A case of parotid gland NUT carcinoma also showed CD56 positivity7; that case had a malignant heterologous mesenchymal component, a possible form of epithelial‐mesenchymal transition (EMT). In our case loss of epithelial marker reactivity focally and gain of vimentin positivity diffusely in the pleural fluid were observed, possibly because of the EMT that is known to be associated with tumor metastasis and a poor prognosis in many cancers.12, 13 Thus, vimentin positivity does not rule out NUT carcinoma. Although the incidence of NUT carcinoma is increasing, it remains a diagnostic challenge, particularly with cytology specimens. Therefore, further research on the cytopathology of NUT carcinoma is needed. Moreover, testing for specific monoclonal NUT antibodies should be performed in all cases of poorly differentiated carcinomas with p63‐positive cancer across all ages. This case is valuable in that both histological and cytological features including rare immunohistochemical results were delineated in the elderly woman.

Disclosure

There are no conflicts of interest to declare.
  13 in total

1.  NUT midline carcinoma of the parotid gland with mesenchymal differentiation.

Authors:  Michael A den Bakker; Berna H Beverloo; Marry M van den Heuvel-Eibrink; Cees A Meeuwis; Liane M Tan; Laura A Johnson; Christopher A French; Geert J L H van Leenders
Journal:  Am J Surg Pathol       Date:  2009-08       Impact factor: 6.394

2.  Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations.

Authors:  Lynette M Sholl; Mizuki Nishino; Saraswati Pokharel; Mari Mino-Kenudson; Christopher A French; Pasi A Janne; Christopher Lathan
Journal:  J Thorac Oncol       Date:  2015-06       Impact factor: 15.609

3.  Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients.

Authors:  Justin A Bishop; Christopher A French; Syed Z Ali
Journal:  Cancer Cytopathol       Date:  2016-07-11       Impact factor: 5.284

4.  NUT carcinoma in children and adults: A multicenter retrospective study.

Authors:  Lauriane Lemelle; Gaëlle Pierron; Paul Fréneaux; Sophie Huybrechts; Alexandra Spiegel; Dominique Plantaz; Morbize Julieron; Sophie Dumoucel; Antoine Italiano; Fréderic Millot; Christophe Le Tourneau; Guy Leverger; Pascal Chastagner; Matthieu Carton; Daniel Orbach
Journal:  Pediatr Blood Cancer       Date:  2017-06-23       Impact factor: 3.167

5.  A rare Japanese case with a NUT midline carcinoma in the nasal cavity: a case report with immunohistochemical and genetic analyses.

Authors:  Shioto Suzuki; Nobuya Kurabe; Hiroshi Minato; Aki Ohkubo; Ippei Ohnishi; Fumihiko Tanioka; Haruhiko Sugimura
Journal:  Pathol Res Pract       Date:  2014-02-22       Impact factor: 3.250

6.  Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck.

Authors:  Nicole G Chau; Shelley Hurwitz; Chelsey M Mitchell; Alexandra Aserlind; Noam Grunfeld; Leah Kaplan; Peter Hsi; Daniel E Bauer; Christopher S Lathan; Carlos Rodriguez-Galindo; Roy B Tishler; Robert I Haddad; Stephen E Sallan; James E Bradner; Christopher A French
Journal:  Cancer       Date:  2016-08-10       Impact factor: 6.860

7.  Usefulness of Nuclear Protein in Testis (NUT) Immunohistochemistry in the Cytodiagnosis of NUT Midline Carcinoma: A Brief Case Report.

Authors:  Heae Surng Park; Yoon Sung Bae; Sun Och Yoon; Beom Jin Lim; Hyun Jun Hong; Jae Y Ro; Soon Won Hong
Journal:  Korean J Pathol       Date:  2014-08-26

8.  Vimentin expression predicts the occurrence of metastases in non small cell lung carcinomas.

Authors:  Maryline Dauphin; Coralie Barbe; Sarah Lemaire; Béatrice Nawrocki-Raby; Eymeric Lagonotte; Gonzague Delepine; Philippe Birembaut; Christine Gilles; Myriam Polette
Journal:  Lung Cancer       Date:  2013-04-04       Impact factor: 5.705

Review 9.  NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment.

Authors:  Christopher A French
Journal:  Pathol Int       Date:  2018-10-26       Impact factor: 2.534

10.  Abrupt Dyskeratotic and Squamoid Cells in Poorly Differentiated Carcinoma: Case Study of Two Thoracic NUT Midline Carcinomas with Cytohistologic Correlation.

Authors:  Taebum Lee; Sangjoon Choi; Joungho Han; Yoon-La Choi; Kyungjong Lee
Journal:  J Pathol Transl Med       Date:  2018-07-27
View more
  3 in total

Review 1.  Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumors.

Authors:  Kyriakos Chatzopoulos; Jennifer M Boland
Journal:  Virchows Arch       Date:  2021-01-06       Impact factor: 4.064

2.  NUT Carcinoma of the Lung:A Case report and Literature Analysis.

Authors:  Rongshuang Zhao; Ze Hua; Xiaodong Hu; Qi Zhang; Jin Zhang; Jian Wang
Journal:  Front Oncol       Date:  2022-07-12       Impact factor: 5.738

3.  Clinicopathological characteristics of primary lung nuclear protein in testis carcinoma: A single-institute experience of 10 cases.

Authors:  Yoon Ah Cho; Yoon-La Choi; Inwoo Hwang; Kyungjong Lee; Jong Ho Cho; Joungho Han
Journal:  Thorac Cancer       Date:  2020-10-03       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.